Elderly Multimorbidity Clinic Model Offers No Sustained Benefit for Patients With Rheumatoid Arthritis

January 21, 2021

Investigators aimed to improve the quality of care by creating effective management plans using the goals of both the patient and physician. During the course of the Elderly Multimorbidity Clinic (EMC) program, 75% of patients accomplished at least 1 of their goals. Unfortunately, no sustained benefits were observed because of low follow-up.

Rheumatoid Arthritis Quiz: Biologics

January 18, 2021

A range of biologic therapies are available as options for treating patients with rheumatoid arthritis who do not respond to first-line conventional DMARDs, but which to choose and why? Test your knowledge of biologics with this quiz.

Talk Health, Not Weight

January 15, 2021

Although the stakes couldn’t be higher and the promotion of healthy behavior is paramount, the emphasis on BMI and weight is likely to yield little benefit. The Association for Size Diversity and Health (ASDAH) developed Health at Every Size (HAES) to take the focus off of weight change and place it more squarely on health, thus supporting people of all sizes to take care of themselves and improve health outcomes.

Trends in Long-Term Lupus Outcomes

January 11, 2021

The reviewers find persistent disease activity and flares despite progress to date. In addition, they point to the persistence of glucocorticoid treatment dependency, comorbidity burden, reduced health-related quality of life, and inconsistent access to high-quality care.

Rheumatology 2021: Quo Vadis?

January 04, 2021

In part 1 of this article series, Dr. Concoff dusts off the crystal ball to envision the future of the practice of rheumatology, in particular the role of telemedicine during the COVID-19 pandemic and beyond.

Managing Rheumatic Disease Patients During the COVID-19 Pandemic

December 17, 2020

In this episode of Overdrive, the Rheumatology Network podcast, Dr. Kim Gorgens interviews Shereen Mahmood, MD, a rheumatologist with the Montefiore Medical Center in South Bronx, New York, to discuss her experience as a physician during the COVID-19 pandemic.

Lupus Patient Perspectives: Self Advocacy

December 01, 2020

In this episode of Overdrive, the Rheumatology Network podcast, Dr. Kim Gorgens interviews two sisters who've turned a negative healthcare experience into a positive force for change in the lupus community through advocacy. They shared their story during the Patient Perspectives session at the annual meeting of the American College of Rheumatology which was held last month. In this interview, they share their story with Dr. Gorgens.

Introducing the Concoff Method: The Interface Between Sports Medicine and Rheumatology

November 25, 2020

In today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.

Direct Costs to Patients for RA Treatment: $12,509-$36,053

November 20, 2020

The annual direct costs for rheumatoid arthritis (RA) patients are estimated to range from $12,509-$36,053. A late diagnosis costs even more and one in 10 new RA cases are usually diagnosed late. In this presentation, Kathryn Johnson, RPh, of CVS Health breaks down the numbers.